The expression level of the nine ICGs in early stage tumor samples was higher than in advanced tumor samples (Figures 7A–C), indicating that TNFRSF14, CD27, and CD200R1 show significant differences in the T, N, and clinical stages (Kruskal-Wallis test, p < 0.05). This evidence concerns the gene CD200R1 and neoplasm.